Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	disaccharide binding	LGALS9B LGALS9	6.60e-05	7	36	2	GO:0048030
GeneOntologyMolecularFunction	galactoside binding	LGALS9B LGALS9	1.13e-04	9	36	2	GO:0016936
GeneOntologyMolecularFunction	oligosaccharide binding	LGALS9B LGALS9	5.88e-04	20	36	2	GO:0070492
GeneOntologyBiologicalProcess	negative regulation of natural killer cell degranulation	LGALS9B LGALS9	1.67e-05	4	35	2	GO:0043322
GeneOntologyBiologicalProcess	positive regulation of regulatory T cell differentiation	LGALS9B BTN2A1 LGALS9	1.95e-05	31	35	3	GO:0045591
GeneOntologyBiologicalProcess	skeletal system development	BMP8B ASXL2 BMP8A DMRT2 ADAMTS4 ANKH ACAN	6.58e-05	615	35	7	GO:0001501
GeneOntologyBiologicalProcess	regulation of natural killer cell degranulation	LGALS9B LGALS9	7.78e-05	8	35	2	GO:0043321
GeneOntologyBiologicalProcess	regulation of regulatory T cell differentiation	LGALS9B BTN2A1 LGALS9	7.82e-05	49	35	3	GO:0045589
GeneOntologyBiologicalProcess	regulatory T cell differentiation	LGALS9B BTN2A1 LGALS9	1.05e-04	54	35	3	GO:0045066
GeneOntologyBiologicalProcess	negative regulation of natural killer cell activation	LGALS9B LGALS9	2.90e-04	15	35	2	GO:0032815
GeneOntologyBiologicalProcess	negative regulation of CD4-positive, alpha-beta T cell proliferation	LGALS9B LGALS9	2.90e-04	15	35	2	GO:2000562
GeneOntologyBiologicalProcess	regulation of macrophage activation	MUC5B LGALS9B LGALS9	3.49e-04	81	35	3	GO:0043030
GeneOntologyBiologicalProcess	diet induced thermogenesis	BMP8B BMP8A	3.74e-04	17	35	2	GO:0002024
GeneOntologyBiologicalProcess	negative regulation of leukocyte degranulation	LGALS9B LGALS9	3.74e-04	17	35	2	GO:0043301
GeneOntologyBiologicalProcess	regulation of oxidoreductase activity	LGALS9B SZT2 LGALS9	3.88e-04	84	35	3	GO:0051341
GeneOntologyBiologicalProcess	natural killer cell degranulation	LGALS9B LGALS9	4.21e-04	18	35	2	GO:0043320
GeneOntologyBiologicalProcess	negative regulation of alpha-beta T cell proliferation	LGALS9B LGALS9	4.70e-04	19	35	2	GO:0046642
GeneOntologyBiologicalProcess	positive regulation of defense response to bacterium	LGALS9B LGALS9	4.70e-04	19	35	2	GO:1900426
GeneOntologyBiologicalProcess	negative regulation of activated T cell proliferation	BTN2A1 LGALS9	5.21e-04	20	35	2	GO:0046007
GeneOntologyBiologicalProcess	regulation of T cell chemotaxis	LGALS9B LGALS9	5.21e-04	20	35	2	GO:0010819
GeneOntologyBiologicalProcess	defense response to bacterium	MUC5B ADAMTS4 LGALS9B IGHM LGALS9	5.69e-04	405	35	5	GO:0042742
GeneOntologyBiologicalProcess	regulation of natural killer cell differentiation	LGALS9B LGALS9	5.76e-04	21	35	2	GO:0032823
GeneOntologyBiologicalProcess	mononuclear cell differentiation	ASXL2 LGALS9B BTN2A1 IGHM IGKC LGALS9	6.57e-04	640	35	6	GO:1903131
GeneOntologyBiologicalProcess	positive regulation of leukocyte differentiation	ASXL2 LGALS9B BTN2A1 LGALS9	7.27e-04	242	35	4	GO:1902107
GeneOntologyBiologicalProcess	positive regulation of hemopoiesis	ASXL2 LGALS9B BTN2A1 LGALS9	7.27e-04	242	35	4	GO:1903708
GeneOntologyBiologicalProcess	negative regulation of T cell proliferation	LGALS9B BTN2A1 LGALS9	7.87e-04	107	35	3	GO:0042130
GeneOntologyBiologicalProcess	regulation of defense response to bacterium	LGALS9B LGALS9	8.86e-04	26	35	2	GO:1900424
GeneOntologyBiologicalProcess	lymphocyte mediated immunity	LGALS9B GNL1 IGHM IGKC LGALS9	9.05e-04	449	35	5	GO:0002449
GeneOntologyBiologicalProcess	regulation of CD4-positive, alpha-beta T cell proliferation	LGALS9B LGALS9	1.03e-03	28	35	2	GO:2000561
GeneOntologyBiologicalProcess	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	LGALS9B GNL1 IGHM IGKC LGALS9	1.03e-03	462	35	5	GO:0002460
GeneOntologyBiologicalProcess	positive regulation of interleukin-6 production	IL17RC LGALS9B LGALS9	1.15e-03	122	35	3	GO:0032755
GeneOntologyBiologicalProcess	CD4-positive, alpha-beta T cell proliferation	LGALS9B LGALS9	1.18e-03	30	35	2	GO:0035739
GeneOntologyBiologicalProcess	transforming growth factor beta receptor signaling pathway	BMP8B BMP8A LGALS9B LGALS9	1.18e-03	276	35	4	GO:0007179
GeneOntologyBiologicalProcess	negative regulation of lymphocyte proliferation	LGALS9B BTN2A1 LGALS9	1.21e-03	124	35	3	GO:0050672
GeneOntologyBiologicalProcess	regulation of lymphocyte chemotaxis	LGALS9B LGALS9	1.26e-03	31	35	2	GO:1901623
GeneOntologyBiologicalProcess	negative regulation of mononuclear cell proliferation	LGALS9B BTN2A1 LGALS9	1.26e-03	126	35	3	GO:0032945
GeneOntologyBiologicalProcess	negative regulation of regulated secretory pathway	LGALS9B LGALS9	1.34e-03	32	35	2	GO:1903306
GeneOntologyBiologicalProcess	corpus callosum development	SZT2 PTPRS	1.43e-03	33	35	2	GO:0022038
GeneOntologyBiologicalProcess	T cell chemotaxis	LGALS9B LGALS9	1.43e-03	33	35	2	GO:0010818
GeneOntologyBiologicalProcess	negative regulation of leukocyte proliferation	LGALS9B BTN2A1 LGALS9	1.51e-03	134	35	3	GO:0070664
GeneOntologyBiologicalProcess	regulation of lymphocyte proliferation	LGALS9B BTN2A1 IGHM LGALS9	1.63e-03	301	35	4	GO:0050670
GeneOntologyBiologicalProcess	macrophage activation	MUC5B LGALS9B LGALS9	1.71e-03	140	35	3	GO:0042116
GeneOntologyBiologicalProcess	regulation of mononuclear cell proliferation	LGALS9B BTN2A1 IGHM LGALS9	1.73e-03	306	35	4	GO:0032944
GeneOntologyBiologicalProcess	regulation of T cell differentiation in thymus	LGALS9B LGALS9	1.79e-03	37	35	2	GO:0033081
GeneOntologyBiologicalProcess	positive regulation of T cell differentiation	LGALS9B BTN2A1 LGALS9	1.85e-03	144	35	3	GO:0045582
GeneOntologyBiologicalProcess	natural killer cell differentiation	LGALS9B LGALS9	1.89e-03	38	35	2	GO:0001779
GeneOntologyBiologicalProcess	leukocyte differentiation	ASXL2 LGALS9B BTN2A1 IGHM IGKC LGALS9	1.93e-03	789	35	6	GO:0002521
GeneOntologyBiologicalProcess	lymphocyte differentiation	LGALS9B BTN2A1 IGHM IGKC LGALS9	2.00e-03	537	35	5	GO:0030098
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated cytotoxicity	LGALS9B LGALS9	2.10e-03	40	35	2	GO:0045953
GeneOntologyBiologicalProcess	negative regulation of CD4-positive, alpha-beta T cell activation	LGALS9B LGALS9	2.10e-03	40	35	2	GO:2000515
GeneOntologyBiologicalProcess	positive regulation of T cell migration	LGALS9B LGALS9	2.20e-03	41	35	2	GO:2000406
GeneOntologyBiologicalProcess	negative regulation of natural killer cell mediated immunity	LGALS9B LGALS9	2.20e-03	41	35	2	GO:0002716
GeneOntologyBiologicalProcess	immune response-activating signaling pathway	PTPRS BTN2A1 IGHM IGKC LGALS9	2.27e-03	553	35	5	GO:0002757
GeneOntologyBiologicalProcess	natural killer cell activation involved in immune response	LGALS9B LGALS9	2.31e-03	42	35	2	GO:0002323
GeneOntologyBiologicalProcess	positive regulation of macrophage activation	LGALS9B LGALS9	2.31e-03	42	35	2	GO:0043032
GeneOntologyBiologicalProcess	regulation of leukocyte proliferation	LGALS9B BTN2A1 IGHM LGALS9	2.33e-03	332	35	4	GO:0070663
GeneOntologyBiologicalProcess	positive regulation of SMAD protein signal transduction	LGALS9B LGALS9	2.42e-03	43	35	2	GO:0060391
GeneOntologyBiologicalProcess	cellular response to transforming growth factor beta stimulus	BMP8B BMP8A LGALS9B LGALS9	2.43e-03	336	35	4	GO:0071560
GeneOntologyBiologicalProcess	positive regulation of lymphocyte differentiation	LGALS9B BTN2A1 LGALS9	2.59e-03	162	35	3	GO:0045621
GeneOntologyBiologicalProcess	response to transforming growth factor beta	BMP8B BMP8A LGALS9B LGALS9	2.62e-03	343	35	4	GO:0071559
GeneOntologyBiologicalProcess	cortical actin cytoskeleton organization	FMNL3 FMNL2	2.65e-03	45	35	2	GO:0030866
GeneOntologyBiologicalProcess	negative regulation of exocytosis	LGALS9B LGALS9	2.65e-03	45	35	2	GO:0045920
GeneOntologyBiologicalProcess	leukocyte mediated immunity	LGALS9B GNL1 IGHM IGKC LGALS9	2.71e-03	576	35	5	GO:0002443
GeneOntologyBiologicalProcess	positive regulation of immune response	LGALS9B PTPRS BTN2A1 IGHM IGKC LGALS9	2.72e-03	845	35	6	GO:0050778
GeneOntologyBiologicalProcess	positive regulation of oxidoreductase activity	LGALS9B LGALS9	2.76e-03	46	35	2	GO:0051353
GeneOntologyBiologicalProcess	base-excision repair	LIG3 HUWE1	2.76e-03	46	35	2	GO:0006284
GeneOntologyBiologicalProcess	response to dietary excess	BMP8B BMP8A	2.88e-03	47	35	2	GO:0002021
GeneOntologyBiologicalProcess	negative regulation of leukocyte mediated cytotoxicity	LGALS9B LGALS9	2.88e-03	47	35	2	GO:0001911
GeneOntologyBiologicalProcess	regulation of T-helper 17 type immune response	LGALS9B LGALS9	2.88e-03	47	35	2	GO:2000316
GeneOntologyBiologicalProcess	positive regulation of interleukin-10 production	LGALS9B LGALS9	3.00e-03	48	35	2	GO:0032733
GeneOntologyBiologicalProcess	negative regulation of T cell activation	LGALS9B BTN2A1 LGALS9	3.02e-03	171	35	3	GO:0050868
GeneOntologyBiologicalProcess	immune response-activating cell surface receptor signaling pathway	BTN2A1 IGHM IGKC LGALS9	3.09e-03	359	35	4	GO:0002429
GeneOntologyBiologicalProcess	positive regulation of lymphocyte migration	LGALS9B LGALS9	3.13e-03	49	35	2	GO:2000403
GeneOntologyBiologicalProcess	negative regulation of type II interferon production	LGALS9B LGALS9	3.39e-03	51	35	2	GO:0032689
GeneOntologyBiologicalProcess	negative regulation of cell killing	LGALS9B LGALS9	3.52e-03	52	35	2	GO:0031342
GeneOntologyBiologicalProcess	negative regulation of alpha-beta T cell activation	LGALS9B LGALS9	3.52e-03	52	35	2	GO:0046636
GeneOntologyBiologicalProcess	positive regulation of cell development	ASXL2 LGALS9B BTN2A1 ACAN LGALS9	3.56e-03	614	35	5	GO:0010720
GeneOntologyBiologicalProcess	immune response-regulating signaling pathway	PTPRS BTN2A1 IGHM IGKC LGALS9	3.59e-03	615	35	5	GO:0002764
GeneOntologyBiologicalProcess	lymphocyte chemotaxis	LGALS9B LGALS9	3.65e-03	53	35	2	GO:0048247
GeneOntologyBiologicalProcess	regulation of alpha-beta T cell proliferation	LGALS9B LGALS9	3.65e-03	53	35	2	GO:0046640
GeneOntologyBiologicalProcess	regulation of activated T cell proliferation	BTN2A1 LGALS9	3.79e-03	54	35	2	GO:0046006
GeneOntologyBiologicalProcess	activation of immune response	PTPRS BTN2A1 IGHM IGKC LGALS9	3.79e-03	623	35	5	GO:0002253
GeneOntologyCellularComponent	IgM immunoglobulin complex	IGHM IGKC	2.99e-04	15	36	2	GO:0071753
MousePheno	autoimmune arthritis	LGALS9B ANKH ACAN IGHM LGALS9	4.28e-06	108	32	5	MP:0002993
MousePheno	joint inflammation	LGALS9B ANKH ACAN IGHM LGALS9	1.10e-05	131	32	5	MP:0002933
MousePheno	epididymis epithelium degeneration	BMP8B BMP8A	1.52e-05	3	32	2	MP:0004934
MousePheno	abnormal joint physiology	LGALS9B ANKH ACAN IGHM LGALS9	1.80e-05	145	32	5	MP:0031169
MousePheno	abnormal Peyer's patch morphology	LGALS9B IGHM IGKC LGALS9	3.66e-05	83	32	4	MP:0000696
MousePheno	abnormal gut-associated lymphoid tissue morphology	LGALS9B IGHM IGKC LGALS9	4.02e-05	85	32	4	MP:0002378
MousePheno	abnormal susceptibility to autoimmune disorder	IL17RC LGALS9B BTN2A1 ACAN IGHM LGALS9	5.98e-05	307	32	6	MP:0002425
MousePheno	increased susceptibility to induced arthritis	LGALS9B IGHM LGALS9	7.39e-05	36	32	3	MP:0003724
MousePheno	epididymis degeneration	BMP8B BMP8A	1.06e-04	7	32	2	MP:0004935
MousePheno	autoimmune response	IL17RC LGALS9B BTN2A1 ACAN IGHM LGALS9	2.48e-04	398	32	6	MP:0001844
MousePheno	abnormal self tolerance	IL17RC LGALS9B BTN2A1 ACAN IGHM LGALS9	2.55e-04	400	32	6	MP:0005005
MousePheno	abnormal immune tolerance	IL17RC LGALS9B BTN2A1 ACAN IGHM LGALS9	2.69e-04	404	32	6	MP:0005000
MousePheno	increased susceptibility to autoimmune disorder	LGALS9B BTN2A1 IGHM LGALS9	4.11e-04	155	32	4	MP:0005350
Domain	Drf_GBD	FMNL3 FMNL2	1.08e-04	9	33	2	PF06371
Domain	FH3_dom	FMNL3 FMNL2	1.08e-04	9	33	2	IPR010472
Domain	GTPase-bd	FMNL3 FMNL2	1.08e-04	9	33	2	IPR010473
Domain	Drf_FH3	FMNL3 FMNL2	1.08e-04	9	33	2	PF06367
Domain	Drf_FH3	FMNL3 FMNL2	1.08e-04	9	33	2	SM01139
Domain	Drf_GBD	FMNL3 FMNL2	1.08e-04	9	33	2	SM01140
Domain	GBD/FH3_dom	FMNL3 FMNL2	1.65e-04	11	33	2	IPR014768
Domain	GBD_FH3	FMNL3 FMNL2	1.65e-04	11	33	2	PS51232
Domain	Inhibin_asu	BMP8B BMP8A	2.33e-04	13	33	2	IPR002405
Domain	Gal-bind_lectin	LGALS9B LGALS9	3.13e-04	15	33	2	SM00908
Domain	GALECTIN	LGALS9B LGALS9	3.13e-04	15	33	2	PS51304
Domain	Galectin_CRD	LGALS9B LGALS9	3.13e-04	15	33	2	IPR001079
Domain	FH2	FMNL3 FMNL2	3.13e-04	15	33	2	PS51444
Domain	Gal-bind_lectin	LGALS9B LGALS9	3.13e-04	15	33	2	PF00337
Domain	GLECT	LGALS9B LGALS9	3.13e-04	15	33	2	SM00276
Domain	FH2_Formin	FMNL3 FMNL2	3.13e-04	15	33	2	IPR015425
Domain	FH2	FMNL3 FMNL2	3.13e-04	15	33	2	PF02181
Domain	FH2	FMNL3 FMNL2	3.13e-04	15	33	2	SM00498
Domain	TGFb_propeptide	BMP8B BMP8A	1.11e-03	28	33	2	PF00688
Domain	TGF-b_N	BMP8B BMP8A	1.11e-03	28	33	2	IPR001111
Domain	TGF-beta-rel	BMP8B BMP8A	1.45e-03	32	33	2	IPR015615
Domain	TGFb_CS	BMP8B BMP8A	1.45e-03	32	33	2	IPR017948
Domain	TGFB	BMP8B BMP8A	1.94e-03	37	33	2	SM00204
Domain	TGF_BETA_2	BMP8B BMP8A	1.94e-03	37	33	2	PS51362
Domain	TGF_beta	BMP8B BMP8A	1.94e-03	37	33	2	PF00019
Domain	TGF-b_C	BMP8B BMP8A	1.94e-03	37	33	2	IPR001839
Domain	TGF_BETA_1	BMP8B BMP8A	1.94e-03	37	33	2	PS00250
Domain	C1-set	IGHM IGKC	4.09e-03	54	33	2	PF07654
Domain	IGc1	IGHM IGKC	4.39e-03	56	33	2	SM00407
Domain	Ig_C1-set	IGHM IGKC	4.70e-03	58	33	2	IPR003597
Domain	Ig/MHC_CS	IGHM IGKC	4.70e-03	58	33	2	IPR003006
Domain	IG_MHC	IGHM IGKC	5.03e-03	60	33	2	PS00290
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC5B MOGS ADAMTS4 ACAN	1.72e-04	143	28	4	M27275
Pathway	REACTOME_RHOC_GTPASE_CYCLE	FMNL3 FMNL2 ARHGAP21	3.51e-04	70	28	3	MM15597
Pathway	KEGG_MEDICUS_REFERENCE_BMP_SIGNALING_PATHWAY_BMP_ANTAGONIST	BMP8B BMP8A	3.93e-04	15	28	2	M47824
Pathway	REACTOME_RHOC_GTPASE_CYCLE	FMNL3 FMNL2 ARHGAP21	4.14e-04	74	28	3	M41807
Pubmed	Galectin-9 regulates the threshold of B cell activation and autoimmunity.	LGALS9B IGHM LGALS9	4.07e-09	4	36	3	34369876
Pubmed	Secreted IgD Amplifies Humoral T Helper 2 Cell Responses by Binding Basophils via Galectin-9 and CD44.	LGALS9B IGHM LGALS9	5.65e-07	16	36	3	30291028
Pubmed	Global comparative transcriptome analysis of cartilage formation in vivo.	BMP8B BMP8A ACAN	5.65e-07	16	36	3	19272164
Pubmed	Human osteoarthritis synovial fluid and joint cartilage contain both aggrecanase- and matrix metalloproteinase-generated aggrecan fragments.	ADAMTS4 ACAN	1.04e-06	2	36	2	16188468
Pubmed	A strategy to identify protein-N-myristoylation-dependent phosphorylation reactions of cellular proteins by using Phos-tag SDS-PAGE.	FMNL3 FMNL2	1.04e-06	2	36	2	31751425
Pubmed	Protein N-myristoylation is required for cellular morphological changes induced by two formin family proteins, FMNL2 and FMNL3.	FMNL3 FMNL2	1.04e-06	2	36	2	22790947
Pubmed	Human BMP8A suppresses luteinization of rat granulosa cells via the SMAD1/5/8 pathway.	BMP8B BMP8A	1.04e-06	2	36	2	31940275
Pubmed	Sites of aggrecan cleavage by recombinant human aggrecanase-1 (ADAMTS-4).	ADAMTS4 ACAN	1.04e-06	2	36	2	10751421
Pubmed	ADAMTS-4_v1 is a splice variant of ADAMTS-4 that is expressed as a protein in human synovium and cleaves aggrecan at the interglobular domain.	ADAMTS4 ACAN	1.04e-06	2	36	2	23897278
Pubmed	The protective role of bone morphogenetic protein-8 in the glucocorticoid-induced apoptosis on bone cells.	BMP8B BMP8A	1.04e-06	2	36	2	21277400
Pubmed	MMP proteolysis of the human extracellular matrix protein aggrecan is mainly a process of normal turnover.	ADAMTS4 ACAN	1.04e-06	2	36	2	22670872
Pubmed	Heavy chain-only antibodies are spontaneously produced in light chain-deficient mice.	IGHM IGKC	1.04e-06	2	36	2	18086860
Pubmed	Bone morphogenetic protein 8A plays a role in the maintenance of spermatogenesis and the integrity of the epididymis.	BMP8B BMP8A	1.04e-06	2	36	2	9463357
Pubmed	The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse.	BMP8B BMP8A	1.04e-06	2	36	2	8682296
Pubmed	FMNL formins boost lamellipodial force generation.	FMNL3 FMNL2	1.04e-06	2	36	2	28327544
Pubmed	Light chain-deficient mice produce novel multimeric heavy-chain-only IgA by faulty class switching.	IGHM IGKC	1.04e-06	2	36	2	19561045
Pubmed	Crystal structure of the galectin-9 N-terminal carbohydrate recognition domain from Mus musculus reveals the basic mechanism of carbohydrate recognition.	LGALS9B LGALS9	3.12e-06	3	36	2	16990264
Pubmed	Galectin-9 Is Critical for Mucosal Adaptive Immunity through the T Helper 17-IgA Axis.	LGALS9B LGALS9	3.12e-06	3	36	2	29458010
Pubmed	Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.	LGALS9B LGALS9	3.12e-06	3	36	2	18005988
Pubmed	Galectin-9 ameliorates clinical severity of MRL/lpr lupus-prone mice by inducing plasma cell apoptosis independently of Tim-3.	LGALS9B LGALS9	3.12e-06	3	36	2	23585851
Pubmed	Galectin-9 ameliorates anti-GBM glomerulonephritis by inhibiting Th1 and Th17 immune responses in mice.	LGALS9B LGALS9	3.12e-06	3	36	2	24477688
Pubmed	Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation.	LGALS9B LGALS9	3.12e-06	3	36	2	19776007
Pubmed	A unique role for galectin-9 in angiogenesis and inflammatory arthritis.	LGALS9B LGALS9	3.12e-06	3	36	2	29433546
Pubmed	Cooperative Interactions of Oligosaccharide and Peptide Moieties of a Glycopeptide Derived from IgE with Galectin-9.	LGALS9B LGALS9	3.12e-06	3	36	2	26582205
Pubmed	Oncogenic miR-93-5p/Gal-9 axis drives CD8 (+) T-cell inactivation and is a therapeutic target for hepatocellular carcinoma immunotherapy.	LGALS9B LGALS9	3.12e-06	3	36	2	37105392
Pubmed	Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin.	LGALS9B LGALS9	3.12e-06	3	36	2	9153289
Pubmed	Galectin-9 regulates follicular helper T cells to inhibit humoral autoimmunity-induced pulmonary fibrosis.	LGALS9B LGALS9	3.12e-06	3	36	2	33316546
Pubmed	Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice.	LGALS9B LGALS9	3.12e-06	3	36	2	18974023
Pubmed	Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin.	LGALS9B LGALS9	3.12e-06	3	36	2	9038233
Pubmed	Cell surface galectin-9 expressing Th cells regulate Th17 and Foxp3+ Treg development by galectin-9 secretion.	LGALS9B LGALS9	3.12e-06	3	36	2	23144904
Pubmed	Impaired Gal-9 Dysregulates the PBMC-Induced Th1/Th2 Imbalance in Abortion-Prone Matings.	LGALS9B LGALS9	3.12e-06	3	36	2	29651447
Pubmed	Evidence that Mothers-against-dpp-related 1 (Madr1) plays a role in the initiation and maintenance of spermatogenesis in the mouse.	BMP8B BMP8A	3.12e-06	3	36	2	9076678
Pubmed	Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson's disease.	LGALS9B LGALS9	3.12e-06	3	36	2	36479526
Pubmed	Protective effect of Galectin-9 in murine model of lung emphysema: Involvement of neutrophil migration and MMP-9 production.	LGALS9B LGALS9	3.12e-06	3	36	2	28704475
Pubmed	The N- and C-terminal carbohydrate recognition domains of galectin-9 contribute differently to its multiple functions in innate immunity and adaptive immunity.	LGALS9B LGALS9	3.12e-06	3	36	2	21146220
Pubmed	Profiling Lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy.	LGALS9B LGALS9	3.12e-06	3	36	2	23242525
Pubmed	Identification and characterization of human FMNL1, FMNL2 and FMNL3 genes in silico.	FMNL3 FMNL2	3.12e-06	3	36	2	12684686
Pubmed	Galectin-9 in allergic airway inflammation and hyper-responsiveness in mice.	LGALS9B LGALS9	3.12e-06	3	36	2	19851072
Pubmed	The Role of Galectin-9 as Mediator of Atopic Dermatitis: Effect on Keratinocytes.	LGALS9B LGALS9	3.12e-06	3	36	2	33923930
Pubmed	Requirement of Bmp8b for the generation of primordial germ cells in the mouse.	BMP8B BMP8A	3.12e-06	3	36	2	10894154
Pubmed	Alarmin function of galectin-9 in murine respiratory tularemia.	LGALS9B LGALS9	3.12e-06	3	36	2	25898318
Pubmed	Amelioration of bleomycin-induced pulmonary fibrosis via TGF-β-induced Smad and non-Smad signaling pathways in galectin-9-deficient mice and fibroblast cells.	LGALS9B LGALS9	3.12e-06	3	36	2	31937306
Pubmed	Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine.	LGALS9B LGALS9	3.12e-06	3	36	2	21426359
Pubmed	Intracellular Galectin-9 Enhances Proximal TCR Signaling and Potentiates Autoimmune Diseases.	LGALS9B LGALS9	3.12e-06	3	36	2	31969388
Pubmed	Galectin-9 protein is up-regulated in astrocytes by tumor necrosis factor and promotes encephalitogenic T-cell apoptosis.	LGALS9B LGALS9	3.12e-06	3	36	2	23836896
Pubmed	Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis.	LGALS9B LGALS9	3.12e-06	3	36	2	18282810
Pubmed	Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs).	BMP8B BMP8A	3.12e-06	3	36	2	12925636
Pubmed	Obesity-induced galectin-9 is a therapeutic target in B-cell acute lymphoblastic leukemia.	LGALS9B LGALS9	3.12e-06	3	36	2	35241678
Pubmed	Sequence and mapping of galectin-5, a beta-galactoside-binding lectin, found in rat erythrocytes.	LGALS9B LGALS9	3.12e-06	3	36	2	7890611
Pubmed	Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner.	LGALS9B LGALS9	3.12e-06	3	36	2	22341088
Pubmed	Regulation of M1‑type and M2‑type macrophage polarization in RAW264.7 cells by Galectin‑9.	LGALS9B LGALS9	3.12e-06	3	36	2	28990062
Pubmed	Galectin-9 Is a Novel Regulator of Epithelial Restitution.	LGALS9B LGALS9	3.12e-06	3	36	2	32380082
Pubmed	Galectin-9 is a suppressor of T and B cells and predicts the immune modulatory potential of mesenchymal stromal cell preparations.	LGALS9B LGALS9	3.12e-06	3	36	2	24083426
Pubmed	Galectin-9-mediated protection from allo-specific T cells as a mechanism of immune privilege of corneal allografts.	LGALS9B LGALS9	3.12e-06	3	36	2	23667648
Pubmed	Galectin-9 in synergy with NF-κB inhibition restores immune regulatory capability in dendritic cells of subjects with food allergy.	LGALS9B LGALS9	3.12e-06	3	36	2	37279535
Pubmed	Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices.	LGALS9B LGALS9	3.12e-06	3	36	2	18579572
Pubmed	The protective function of galectin-9 in liver ischemia and reperfusion injury in mice.	LGALS9B LGALS9	3.12e-06	3	36	2	25931247
Pubmed	BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions.	BMP8B BMP8A	3.12e-06	3	36	2	22579288
Pubmed	Possible regulatory role of galectin-9 on Ascaris suum-induced eosinophilic lung inflammation in mice.	LGALS9B LGALS9	3.12e-06	3	36	2	22627368
Pubmed	Mutation in Bmp7 exacerbates the phenotype of Bmp8a mutants in spermatogenesis and epididymis.	BMP8B BMP8A	3.12e-06	3	36	2	11784057
Pubmed	Regulatory T Cell-Mediated Suppression of Inflammation Induced by DR3 Signaling Is Dependent on Galectin-9.	LGALS9B LGALS9	3.12e-06	3	36	2	28877989
Pubmed	Galectin-9 is required for endometrial regenerative cells to induce long-term cardiac allograft survival in mice.	LGALS9B LGALS9	3.12e-06	3	36	2	33153471
Pubmed	Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages.	LGALS9B LGALS9	3.12e-06	3	36	2	19800850
Pubmed	T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.	LGALS9B LGALS9	3.12e-06	3	36	2	22052881
Pubmed	Galectin-9 protects mice from the Shwartzman reaction by attracting prostaglandin E2-producing polymorphonuclear leukocytes.	LGALS9B LGALS9	3.12e-06	3	36	2	17560833
Pubmed	The effect of Toxoplasma gondii infection on galectin-9 expression in decidual macrophages contributing to dysfunction of decidual NK cells during pregnancy.	LGALS9B LGALS9	3.12e-06	3	36	2	38987795
Pubmed	Galectin-9 supports primary T cell transendothelial migration in a glycan and integrin dependent manner.	LGALS9B LGALS9	3.12e-06	3	36	2	35643073
Pubmed	Galectin-9 functionally impairs natural killer cells in humans and mice.	LGALS9B LGALS9	3.12e-06	3	36	2	23408620
Pubmed	Estrogen mediated epithelial proliferation in the uterus is directed by stromal Fgf10 and Bmp8a.	BMP8B BMP8A	3.12e-06	3	36	2	25451979
Pubmed	FMNL2 and -3 regulate Golgi architecture and anterograde transport downstream of Cdc42.	FMNL3 FMNL2	3.12e-06	3	36	2	28852060
Pubmed	Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia.	LIG3 MOGS NUP107 NOL6	4.13e-06	104	36	4	26167872
Pubmed	Integrated Transcriptome and Network Analysis Reveals Spatiotemporal Dynamics of Calvarial Suturogenesis.	BMP8B BMP8A MLIP	5.44e-06	33	36	3	32640236
Pubmed	Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response.	LGALS9B LGALS9	6.24e-06	4	36	2	20463811
Pubmed	SARS-Cov-2 spike induces intestinal barrier dysfunction through the interaction between CEACAM5 and Galectin-9.	LGALS9B LGALS9	6.24e-06	4	36	2	38686388
Pubmed	Contrasting acute graft-versus-host disease effects of Tim-3/galectin-9 pathway blockade dependent upon the presence of donor regulatory T cells.	LGALS9B LGALS9	6.24e-06	4	36	2	22677125
Pubmed	Lumenal Galectin-9-Lamp2 interaction regulates lysosome and autophagy to prevent pathogenesis in the intestine and pancreas.	LGALS9B LGALS9	6.24e-06	4	36	2	32855403
Pubmed	Galectin-3 mediates oligomerization of secreted hensin using its carbohydrate-recognition domain.	LGALS9B LGALS9	6.24e-06	4	36	2	23657851
Pubmed	Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators.	LGALS9B LGALS9	6.24e-06	4	36	2	19234217
Pubmed	[Expression and significance of galectin-3 and galectin-9 in mice nasal mucosa with allergic rhinitis].	LGALS9B LGALS9	6.24e-06	4	36	2	18826117
Pubmed	The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis.	LGALS9B LGALS9	6.24e-06	4	36	2	24333756
Pubmed	The expression of Galectin-9 correlates with mTOR and AMPK in murine colony-forming erythroid progenitors.	LGALS9B LGALS9	6.24e-06	4	36	2	38853593
Pubmed	Characterization and chromosomal localization of PTPRO, a novel receptor protein tyrosine phosphatase, expressed in hematopoietic stem cells.	BMP8B BMP8A	6.24e-06	4	36	2	9434160
Pubmed	Evidence that mouse Bmp8a (Op2) and Bmp8b are duplicated genes that play a role in spermatogenesis and placental development.	BMP8B BMP8A	6.24e-06	4	36	2	8843393
Pubmed	Tim-3/Galectin-9 signaling pathway is involved in the cytokine changes in mice with alveolar echinococcosis.	LGALS9B LGALS9	6.24e-06	4	36	2	35715604
Pubmed	Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies.	LGALS9B LGALS9	6.24e-06	4	36	2	24958847
Pubmed	Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.	LGALS9B LGALS9	6.24e-06	4	36	2	19017954
Pubmed	Galectin-9 binds IgM-BCR to regulate B cell signaling.	LGALS9B LGALS9	6.24e-06	4	36	2	30120235
Pubmed	Galectin-9 Targets NLRP3 for Autophagic Degradation to Limit Inflammation.	LGALS9B LGALS9	6.24e-06	4	36	2	33963043
Pubmed	Galectin-9: A novel promoter of atherosclerosis progression.	LGALS9B LGALS9	6.24e-06	4	36	2	36459823
Pubmed	[Expression of Galectin-9 and Tim-3 in lungs of mice with asthma].	LGALS9B LGALS9	6.24e-06	4	36	2	21575348
Pubmed	Activation of Tim-3-Galectin-9 pathway improves survival of fully allogeneic skin grafts.	LGALS9B LGALS9	6.24e-06	4	36	2	18346632
Pubmed	Isolation and characterization of a novel eosinophil-specific galectin released into the lungs in response to allergen challenge.	LGALS9B LGALS9	6.24e-06	4	36	2	11839756
Pubmed	Newly characterized decidual Tim-3+ Treg cells are abundant during early pregnancy and driven by IL-27 coordinately with Gal-9 from trophoblasts.	LGALS9B LGALS9	6.24e-06	4	36	2	33107565
Pubmed	Attenuation of Th1 response through galectin-9 and T-cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice.	LGALS9B LGALS9	6.24e-06	4	36	2	19670381
Pubmed	Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models.	LGALS9B LGALS9	6.24e-06	4	36	2	29611821
Pubmed	Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway.	LGALS9B LGALS9	6.24e-06	4	36	2	30763585
Pubmed	Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury.	LGALS9B LGALS9	6.24e-06	4	36	2	25450716
Pubmed	The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity.	LGALS9B LGALS9	6.24e-06	4	36	2	16286920
Pubmed	Lgals9 deficiency ameliorates obesity by modulating redox state of PRDX2.	LGALS9B LGALS9	6.24e-06	4	36	2	33727589
Pubmed	Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells.	LGALS9B LGALS9	6.24e-06	4	36	2	19362679
Interaction	ENPP4 interactions	IL17RC ANKH LGALS9	1.32e-05	26	36	3	int:ENPP4
Interaction	LUM interactions	LGALS9B ACAN LGALS9	2.51e-05	32	36	3	int:LUM
Cytoband	Ensembl 112 genes in cytogenetic band chr1p34	SLC6A9 BMP8B BMP8A SZT2	8.26e-05	294	36	4	chr1p34
Cytoband	13q12	SACS PCOTH	1.63e-04	24	36	2	13q12
Cytoband	9p13.3	PHF24 NOL6	1.60e-03	75	36	2	9p13.3
GeneFamily	Bone morphogenetic proteins\|Astacins	BMP8B BMP8A	7.02e-05	11	21	2	455
GeneFamily	Galectins	LGALS9B LGALS9	1.34e-04	15	21	2	629
Coexpression	CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN	BMP8B BMP8A LGALS9B LGALS9	4.74e-05	146	36	4	MM973
Coexpression	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3	BMP8B BMP8A	5.11e-05	8	36	2	M10331
Coexpression	BYSTRYKH_HEMATOPOIESIS_STEM_CELL_FGF3	BMP8B BMP8A	6.56e-05	9	36	2	MM608
Coexpression	MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3	BMP8B BMP8A ACAN	8.51e-05	62	36	3	MM829
Coexpression	MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3	BMP8B BMP8A DMRT2 ACAN PHF24	1.21e-04	357	36	5	MM828
Coexpression	MEBARKI_HCC_PROGENITOR_FZD8CRD_UP	FMNL3 LIG3 RGS9 NUP107 SACS CDCA5	1.36e-04	588	36	6	M38992
Coexpression	GSE2405_HEAT_KILLED_LYSATE_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_9H_UP	DMRT2 CDCA5 IGHM IGKC	1.57e-04	199	36	4	M6198
Coexpression	GSE8835_CD4_VS_CD8_TCELL_UP	LIG3 ASXL2 HUWE1 NOL6	1.60e-04	200	36	4	M6254
Coexpression	GSE27786_LSK_VS_CD4_TCELL_DN	FMNL3 ASXL2 GNL1 IGKC	1.60e-04	200	36	4	M4747
ToppCell	mild-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FMNL3 PTPRS IGHM IGKC	1.21e-05	176	36	4	59a9c262c252b7d220a025837922d98e9d6b0a24
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	SLC6A9 BMP8B BMP8A IGKC	1.24e-05	177	36	4	4c434a7b7cc54cf4dac996bbc3f5124d9ef9a9cd
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLC6A9 BMP8B BMP8A IGKC	1.24e-05	177	36	4	fc40918825b7e1eb6861df59dfca944778a64b98
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	SLC6A9 BMP8B BMP8A IGKC	1.24e-05	177	36	4	d746122bf8d208c3aa4d156e8c12d0a0e555c6e5
ToppCell	Healthy_donor-Plasmablast\|Healthy_donor / disease group, cell group and cell class (v2)	SLC6A9 BMP8B CDCA5 IGKC	1.26e-05	178	36	4	388b8b4fa20dcc6e9ae4b06118e20b2c20c52bde
ToppCell	PBMC-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	SLC6A9 BMP8B BMP8A IGKC	1.29e-05	179	36	4	494febe77c6d4e6a2c6f0928bbf4c84b0301f188
ToppCell	metastatic_Lymph_Node-Myeloid_cells-pDCs\|Myeloid_cells / Location, Cell class and cell subclass	ADAMTS4 PTPRS IGHM IGKC	1.38e-05	182	36	4	02e04294fce12591c32d7bd0e866a000ad1f836e
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgA_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	SLC6A9 BMP8B BMP8A IGKC	1.50e-05	186	36	4	e2c050ba02e1f84f0b7258dc92e7ff6ab349ff67
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMNL3 PTPRS IGHM IGKC	1.50e-05	186	36	4	0096a61b1841784c913752b4f3639200446cc02c
ToppCell	TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma-2\|TCGA-Kidney / Sample_Type by Project: Shred V9	FMNL3 BMP8A ADAMTS4 ACAN	1.50e-05	186	36	4	1e6526fc9e9381b7ace864588cc7bd80194338d6
ToppCell	control-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FMNL3 PTPRS IGHM IGKC	1.50e-05	186	36	4	fccee4cfcc887358cf916d974f29627095b5ad9c
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMNL3 PTPRS IGHM IGKC	1.50e-05	186	36	4	9e159ad7289dcae2ec7ce655df746f46801b81d3
ToppCell	5'-Airway_Nasal-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	FMNL3 PTPRS IGHM IGKC	1.50e-05	186	36	4	6345777847960c71a2ba3ce5a49c72c34ebd0e73
ToppCell	5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BMP8A CDCA5 IGHM IGKC	1.57e-05	188	36	4	6844cebca177fdf38b21a40d606230a033717a3a
ToppCell	severe_COVID-19-Plasmablast\|World / disease group, cell group and cell class (v2)	SLC6A9 BMP8B CDCA5 IGKC	1.57e-05	188	36	4	25ca19af4ac419a0f5026a6ccbd8b554b268a6f3
ToppCell	healthy_donor-Lymphocytic-Plasma_cell\|healthy_donor / Disease condition, Lineage, Cell class and subclass	SLC6A9 BMP8B BMP8A IGKC	1.57e-05	188	36	4	bd53b0371154cff680226897b61c9809a239d1b6
ToppCell	myeloid-pDC\|myeloid / Lineage and Cell class	FMNL3 PTPRS IGHM IGKC	1.57e-05	188	36	4	a2dc4bbeca2bdc00c51825dd65a699c54c72f241
ToppCell	BAL-Severe-Lymphocyte-B\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BMP8B CDCA5 IGHM IGKC	1.63e-05	190	36	4	e82fefea5ac03470d10463832d3efd2380895860
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BMP8B CDCA5 IGHM IGKC	1.63e-05	190	36	4	7fbaf46bf24d46543047582f0d262f3523e28eb4
ToppCell	BAL-Severe-Lymphocyte-B-Plasmablast\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BMP8B CDCA5 IGHM IGKC	1.63e-05	190	36	4	9560722facaf3516936fcbc2a900a405fd85e5d0
ToppCell	Control-pDC-\|Control / Disease condition and Cell class	FMNL3 PTPRS IGHM IGKC	1.67e-05	191	36	4	1d7b0fae4d114d6db933c18b4eb2066ffa61356d
ToppCell	Control-pDC\|Control / Disease condition and Cell class	FMNL3 PTPRS IGHM IGKC	1.67e-05	191	36	4	543e1437a52d04436862dd1c27b4fae95c44fcc8
ToppCell	Severe-Lymphoid-Plasma-\|Severe / Condition, Lineage, Cell class and cell subclass	BMP8B CDCA5 IGHM IGKC	1.70e-05	192	36	4	3a900d872da80b47104245440eb09b8c80b0b2b0
ToppCell	Severe-Lymphoid-Plasma\|Severe / Condition, Lineage, Cell class and cell subclass	BMP8B CDCA5 IGHM IGKC	1.70e-05	192	36	4	8d26584c7897a2c77df9efe787e7c04d1e883df9
ToppCell	3'-Broncho-tracheal-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	BMP8A CDCA5 IGHM IGKC	1.70e-05	192	36	4	b9c606547c303a099a653169923a44c20816a604
ToppCell	Healthy-pDC\|Healthy / disease group, cell group and cell class	FMNL3 PTPRS IGHM IGKC	1.70e-05	192	36	4	33d695a28d22b4af111df9591830a33bb7ef7b2d
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-B-B_plasma-B_plasmablast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BMP8B BMP8A IGHM IGKC	1.81e-05	195	36	4	c6e31038be2463f1601d52c82efa4e9facb8228f
ToppCell	metastatic_Brain-T/NK_cells-Undetermined\|T/NK_cells / Location, Cell class and cell subclass	NUP107 CDCA5 IGHM IGKC	1.84e-05	196	36	4	c17e105e47446a48aa06e1a3810828e20aa56ea9
ToppCell	wk_15-18-Hematologic_Lymphocytic-B-Large_pre-B\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	CDCA5 IGHM IGKC LGALS9	1.88e-05	197	36	4	7e0834b3947031bf244a10624dcf3f2095c79368
ToppCell	Influenza-Influenza_Severe-Myeloid-pDC\|Influenza_Severe / Disease, condition lineage and cell class	FMNL3 PTPRS IGHM IGKC	1.88e-05	197	36	4	e8e6f71e6dc8a695e4321a18543c1df63dd62f3e
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-B-B_plasma-B_plasmablast\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	BMP8B CDCA5 IGHM IGKC	1.92e-05	198	36	4	cfbe0bae21b6cd9cd15d3e659b618b44cfe3eaec
ToppCell	Sepsis-Leuk-UTI-Others\|Leuk-UTI / Disease, condition lineage and cell class	FMNL3 PTPRS IGHM IGKC	1.96e-05	199	36	4	e45fe91f1d1c47a305b0f39d808730723852af00
ToppCell	Sepsis-Leuk-UTI-Myeloid-pDC\|Leuk-UTI / Disease, condition lineage and cell class	FMNL3 PTPRS IGHM IGKC	1.96e-05	199	36	4	2f8d297afd26ae1e9fb66d8573274452c4133b6c
ToppCell	Sepsis-ICU-SEP-Lymphocyte-B-Plasmablast\|ICU-SEP / Disease, condition lineage and cell class	SLC6A9 BMP8B CDCA5 IGKC	1.96e-05	199	36	4	09f02aaedf19f895a7b6f8eb939fd346b1df75f1
ToppCell	Sepsis-Leuk-UTI-Others-RBC\|Leuk-UTI / Disease, condition lineage and cell class	FMNL3 PTPRS IGHM IGKC	1.96e-05	199	36	4	d9b517199a646c9461c615412ad5b58cf4bed7c8
ToppCell	COVID-19_Severe-NK_activated\|COVID-19_Severe / Disease condition and Cell class	LGALS9B IGHM IGKC LGALS9	2.00e-05	200	36	4	f1f6c7f7f75f891c9ccf6bf58f4d65b9cf10bbd8
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial-Glia_progenitor_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	BMP8B DMRT2 ACAN LGALS9	2.00e-05	200	36	4	6c1b7b0f3cd35d8cfee181ea83c73127dbc41ac5
ToppCell	(6)_Macrophage-(60)_Macrophage\|(6)_Macrophage / shred on Cell_type and subtype	ANKH IGHM IGKC	2.93e-05	74	36	3	356978d2ee61e7042d7a9ad3bc744d3e7a7f76c0
ToppCell	Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	IRS4 DMRT2 IGKC	7.43e-05	101	36	3	cf52c93f523c5f25bd45519a1444ce7bd1d8b577
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Tacstd2\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	RGS9 IRS4 DMRT2	1.21e-04	119	36	3	e868453c02dcf0e07821886b81ca739887d43c67
ToppCell	Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-ILC\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BMP8B CDCA5 IGKC	1.43e-04	126	36	3	e33957cf1541733b06de9f9e7b2801b3d8ae831d
ToppCell	LPS-antiTNF-Myeloid-Dendritic_cells-pDC\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRS IGHM IGKC	1.53e-04	129	36	3	454bae525f6db3d0dd6347d2a2c3ea9dda9cd212
ToppCell	LPS_only-Myeloid-Dendritic_cells-pDC\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRS IGHM IGKC	1.75e-04	135	36	3	0afe232aa1a1e6c37a5b3183b67d7fa07e0ea791
ToppCell	LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-pDC\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRS IGHM IGKC	2.49e-04	152	36	3	0c6dd41142e4ca1e54ca41e05e42ed29fbf0e570
ToppCell	COVID-19_Moderate-multiplets\|World / disease group, cell group and cell class	ACAN IGHM IGKC	2.68e-04	156	36	3	afdc025fa75e7926b1cc182c4a33654a2186abb1
ToppCell	390C-Lymphocytic-Plasma_cell\|390C / Donor, Lineage, Cell class and subclass (all cells)	BMP8B IGHM IGKC	2.68e-04	156	36	3	0de2fc695bd5f8d4633c514f71ea941c88137bac
ToppCell	390C-Lymphocytic-Plasma_cell-\|390C / Donor, Lineage, Cell class and subclass (all cells)	BMP8B IGHM IGKC	2.68e-04	156	36	3	4f92ca30755430db44402afc603d1ecd8bfc3617
ToppCell	PND28-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDCA5 IGHM IGKC	2.73e-04	157	36	3	6730b775308f45a2f3946016bdbb7f8e5b5efe49
ToppCell	LPS-IL1RA-Myeloid-Dendritic_cells-pDC\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PTPRS IGHM IGKC	2.89e-04	160	36	3	dee756a2dc9725520d439e7273c489c2284015d8
ToppCell	Mild-Lymphoid-Plasma-\|Mild / Condition, Lineage, Cell class and cell subclass	PTPRS IGHM IGKC	2.89e-04	160	36	3	aa79848913910c01249d6cacf4ed53ec0e4f5c3d
ToppCell	Mild-Lymphoid-Plasma\|Mild / Condition, Lineage, Cell class and cell subclass	PTPRS IGHM IGKC	2.89e-04	160	36	3	7fdb849f5caf5a127a2582326215e11f8eb4fa0e
ToppCell	droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MOGS NUP107 PHF24	2.89e-04	160	36	3	8a7a73b0ee1877fe02d47f745d36ae2858b529e1
ToppCell	5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgA_plasma_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	BMP8A IGHM IGKC	2.89e-04	160	36	3	e44b3c74c76b4632ada7f5bd6d09434b02d79743
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BMP8A IGHM IGKC	3.00e-04	162	36	3	ee6f05620f4f4ebbebd5b098afc7c20876e3d21f
ToppCell	kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	BMP8A IGHM IGKC	3.00e-04	162	36	3	9e72d468fcdd0d27b517a9e36efb35d4617a88f9
ToppCell	368C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	IGHM IGKC	3.04e-04	32	36	2	f9624fe102388755e72d5a9a34afebaf77127961
ToppCell	356C-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	PTPRS IGHM IGKC	3.05e-04	163	36	3	ae9c5eb19657ea94b7f2357cbc8679acd697b8fe
ToppCell	Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SLC6A9 BMP8A ADAMTS4	3.05e-04	163	36	3	8f24cef152f5965727bbeee116bd26c75cbba82a
ToppCell	PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDCA5 IGHM IGKC	3.11e-04	164	36	3	249d8f75a64bce7db52ce0c563f496b9edf602a6
ToppCell	343B-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PTPRS IGHM IGKC	3.11e-04	164	36	3	cf62d34ce9dd220fe61748466c84fd70d9ba697c
ToppCell	343B-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PTPRS IGHM IGKC	3.11e-04	164	36	3	e00549bc8b3a5566f39031f39d7e698b0b107a7f
ToppCell	PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDCA5 IGHM IGKC	3.16e-04	165	36	3	953c8242a81a39ade63ac8e5b34fe58575771746
ToppCell	-SSc-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	RGS9 IGHM IGKC	3.22e-04	166	36	3	bc9323de1373fdc0357e6bb46874f6c4787443a9
ToppCell	severe-Myeloid-pDC\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	PTPRS IGHM IGKC	3.22e-04	166	36	3	ae38850fde549b8dd6fb12f0ef80b428ade50485
ToppCell	healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast\|healthy_donor / Disease condition, Lineage, Cell class and subclass	BMP8B IGHM IGKC	3.22e-04	166	36	3	2b7b580bec8d9467b0deaf97098065f72dbf2a4f
ToppCell	390C-Lymphocytic-Plasma_cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BMP8B IGHM IGKC	3.22e-04	166	36	3	4ba3711a02d3695b27f7cefd7c60e3be009f5bef
ToppCell	390C-Lymphocytic-Plasma_cell-\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	BMP8B IGHM IGKC	3.22e-04	166	36	3	35f6ae2664935dda0d883b32a050ced843204f2d
ToppCell	10x5'-Lung-Myeloid_Dendritic-pDC\|Lung / Manually curated celltypes from each tissue	PTPRS IGHM IGKC	3.34e-04	168	36	3	90f713dae3fcbd6ca801a019e3861c263ff3366b
ToppCell	PCW_07-8.5-Immune_Lymphocytic-Immune_Lymphocytic_B-im_B_cell_(15)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BMP8B IGHM IGKC	3.34e-04	168	36	3	2ec53f91de3bff8a106430a78b81ee6870f0c55e
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells-Pro-B\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHM IGKC LGALS9	3.39e-04	169	36	3	7fd13b6e6041032697d36dd215f6b943d4675cf2
ToppCell	Healthy_Control-Lymphoid-pDC\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	PTPRS IGHM IGKC	3.39e-04	169	36	3	a4e9b8b2f0338203455ba941b8f99bf4884d26f0
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	BMP8B PTPRS IGKC	3.39e-04	169	36	3	9ab34f602d46ce87283d243b81621e8806504f43
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	BMP8B PTPRS IGKC	3.39e-04	169	36	3	89fbafdb4628ce7a90c50398870e0f8ee90cfd91
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	BMP8B PTPRS IGKC	3.39e-04	169	36	3	75d367eb35768d3063096e8866cea649dac3b1bd
ToppCell	Healthy_Control-Lymphoid-pDC-\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	PTPRS IGHM IGKC	3.39e-04	169	36	3	338ce99897cb522b86edd603f75bc15ec4dfcda3
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-stromal_related-FDC\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGS9 BMP8A FMNL2	3.39e-04	169	36	3	49a54fb2ea9db5c45e107f304838c536908308bb
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRS IGHM IGKC	3.45e-04	170	36	3	92e765ae0d3adb38d3b22fddb873fd5ccad3fd44
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BMP8B PTPRS IGKC	3.45e-04	170	36	3	7dcb6319ba4d7b258dd0a17449d837800ef46ccc
ToppCell	3'-GW_trimst-1-LargeIntestine-Hematopoietic-B_cells\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHM IGKC LGALS9	3.45e-04	170	36	3	e319ab46842d028898c09d6d8f056f896edb1558
ToppCell	367C-Myeloid-Dendritic-pDC\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	PTPRS IGHM IGKC	3.45e-04	170	36	3	fbb7019c6fba87326702b51f6819ea1af5f3a9b7
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRS IGHM IGKC	3.45e-04	170	36	3	9f8b215caa1afa3cd7104c06fca7cfd790640f66
ToppCell	5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	PTPRS IGHM IGKC	3.45e-04	170	36	3	b49f7c8a27078de2137ed04f74cfee30729cfa5e
ToppCell	PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDCA5 IGHM IGKC	3.45e-04	170	36	3	e08a6c5ac34c456da8c7318f104e06fca585be1f
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BMP8B PTPRS IGKC	3.45e-04	170	36	3	7377e59fba4bf97ba893ccf6b5e149b5152407be
ToppCell	BAL-Control-Lymphocyte-B-Plasmablast\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	BMP8B PTPRS IGKC	3.45e-04	170	36	3	e18211029e9ffad54458fd921f455172aad407c7
ToppCell	saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SACS IGHM IGKC	3.45e-04	170	36	3	32917888c3f1d54302675c1d4de1fd3b7c79af5f
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHM IGKC LGALS9	3.51e-04	171	36	3	a350a5f840e0fb0ccd29bb29cacc23a89abd8404
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-Pro-B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHM IGKC LGALS9	3.51e-04	171	36	3	e0a99ca8d4c86b58f54af7755ffd8e0ffbfae5e1
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pro-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHM IGKC LGALS9	3.51e-04	171	36	3	58bdcbc65062ac09f1c014e08302f938a3e6b252
ToppCell	Control-B_cell-Plasmablast\|Control / Disease group,lineage and cell class （2021.01.30）	BMP8B PTPRS IGKC	3.51e-04	171	36	3	c09afc4b111b2b5acca75177554f6364ee02d37c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	FMNL2 IGHM IGKC	3.51e-04	171	36	3	a2938e56cb5749004317798dc7ac0f0c2d4d8ae0
ToppCell	COVID-pDC\|COVID / Condition, Cell_class and T cell subcluster	PTPRS IGHM IGKC	3.57e-04	172	36	3	3ecbb000495dde32f6153ef6bdea9c8802ff3985
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_prolif\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CDCA5 IGHM IGKC	3.57e-04	172	36	3	76c06a968d3333441eed103abef1e636a1c3e7a1
ToppCell	COVID-pDC-\|COVID / Condition, Cell_class and T cell subcluster	PTPRS IGHM IGKC	3.57e-04	172	36	3	a7827faa1afab51fdaf0cb1a2babcd2e00d411e5
ToppCell	3'-GW_trimst-2-LargeIntestine-Hematopoietic-B_cells-Pre-B\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	IGHM IGKC LGALS9	3.63e-04	173	36	3	67c342295b8a06ce38e081ba74478c568917a396
ToppCell	COVID-19_Mild-PLT_2\|COVID-19_Mild / Disease Group and Platelet Clusters	LIG3 ASXL2 NOL6	3.63e-04	173	36	3	d11705e56b6b21eec963ea224717f27680c781ed
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC5B DMRT2 LGALS9B	3.63e-04	173	36	3	464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCell	droplet-Marrow-nan-24m-Myeloid-basophil\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SLC6A9 BMP8B MOGS	3.63e-04	173	36	3	6d2ceba4f89a228600e2b40aba81bb0eb81578c0
ToppCell	BAL-Control-Myeloid-pDC-pDC-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	PTPRS IGHM IGKC	3.70e-04	174	36	3	ab654e87c7eab7f33adc61be7a86da5c4d88008d
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	MUC5B MLIP LGALS9B	3.70e-04	174	36	3	7d2f802f493f19a068e097b2909a9000e2160266
Computational	Genes in the cancer module 547.	NUP107 IGHM	4.72e-04	16	22	2	MODULE_547
Computational	Genes in the cancer module 313.	NUP107 IGHM	6.70e-04	19	22	2	MODULE_313
Computational	Genes in the cancer module 240.	NUP107 IGHM	7.43e-04	20	22	2	MODULE_240
Computational	Genes in the cancer module 156.	NUP107 IGHM	9.01e-04	22	22	2	MODULE_156
Disease	degenerative disc disease (biomarker_via_orthology)	ADAMTS4 ACAN	6.63e-05	11	33	2	DOID:90 (biomarker_via_orthology)
Disease	diabetes mellitus (implicated_via_orthology)	BMP8B BMP8A	3.88e-04	26	33	2	DOID:9351 (implicated_via_orthology)
Disease	azoospermia (implicated_via_orthology)	DMRT2 PTPRS	4.18e-04	27	33	2	DOID:14227 (implicated_via_orthology)
Disease	glycocholate measurement	FMNL2 NOL6	5.17e-04	30	33	2	EFO_0010491
Disease	obesity (implicated_via_orthology)	BMP8B BMP8A ADAMTS4	1.77e-03	215	33	3	DOID:9970 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PAVQSPRRSPRISFF	CDCA5	71	Q96FF9
IRFRFRGETFPPFIV	CXorf58	101	Q96LI9
FHPSQVSPRARFPVS	ASXL2	631	Q76L83
PLIFTFVPTVRRLPT	MLIP	31	Q5VWP3
RRVSFVPPVTVFPSL	MUC5B	51	Q9HC84
PFASPSRFIRRPSTT	RGS9	506	O75916
VIPRTPSSFRQPFTP	NUP107	51	P57740
RTVPVQPAFSTVPFS	LGALS9B	151	Q3B8N2
RTVPVQPAFSTVPFS	LGALS9	151	O00182
TEVFPPTPVRPAFSF	NOL6	696	Q9H6R4
PTPVRPAFSFYETLR	NOL6	701	Q9H6R4
VVLFTSFPRDPRTPQ	GNL1	251	P36915
TRVSPIFPFSPRSPF	PCOTH	31	Q58A44
PPSTPDFSRLRRYFV	LIG3	946	P49916
TPTPRFRLTFFICSV	HUWE1	1121	Q7Z6Z7
FPSVRPFPSVELFPS	ACAN	806	P16112
PVPLFTAVPSRSFFP	MOGS	431	Q13724
RPYIAARFSVLPPTF	PTPRS	1206	Q13332
LRYSFFVPRPTPSTP	ADAMTS4	796	O75173
RSAFSPPRRNFSPIV	DMRT2	426	Q9Y5R5
AIRVFAIPPSFASIF	IGHM	221	P01871
PKTTPPSVFFPVFVR	FMNL3	906	Q8IVF7
PFVVTFFRASPSPIR	BMP8A	246	Q7Z5Y6
FFRASPSPIRTPRAV	BMP8A	251	Q7Z5Y6
LRIFSFFPVPVTVRA	ANKH	371	Q9HCJ1
PRSAFSVPVRPFFRL	BTN2A1	476	Q7KYR7
PPSVFFPVFVRFVKA	FMNL2	966	Q96PY5
RTVAAPSVFIFPPSD	IGKC	1	P01834
PFVVTFFRASPSPIR	BMP8B	246	P34820
FFRASPSPIRTPRAV	BMP8B	251	P34820
FPGTFFRFPLRLQPS	SACS	266	Q9NZJ4
PDAVPALFRTVPVFT	IL17RC	711	Q8NAC3
VSVPASFFRRLAPSP	IRS4	426	O14654
PRPFLLVPSTRVTFL	SZT2	76	Q5T011
TSRFTPPAFIRPTRK	PHF24	96	Q9UPV7
TLLPVQRSFFLPPFS	SLC6A9	31	P48067
SPRSVGPFALTVVPF	TRAPPC9	1051	Q96Q05
FPVFPTALTSERLFR	ARHGAP21	1641	Q5T5U3
VNFFRPFTRFLVPFT	TRMT10C	11	Q7L0Y3